Efficacy and Safety of Tocovid Suprabio 200mg in Non-alcoholic Fatty Liver (NAFL)

PHASE2CompletedINTERVENTIONAL

Enrollment

170

Participants

Timeline

Start Date

January 1, 2021

Primary Completion Date

August 15, 2023

Study Completion Date

October 1, 2023

Conditions

Hepatic SteatosisNAFLD

Interventions

DRUG

Tocotrienols / Vitamin E

Palm Tocotrienols complex

DRUG

Placebo control

Placebo matching Tocovid Suprabio

Trial Locations (4)

KK Bandar Baru Air Itam, Pulau Pinang

KK Jalan Perak, Pulau Pinang

KK Bayan Baru, Pulau Pinang

Hospital Seberang Jaya (CRC), Seberang Jaya

All Listed Sponsors

collaborator

Monash University Malaysia

OTHER

collaborator

Hovid Berhad

INDUSTRY

lead

Yuen Kah Hay

OTHER

NCT04704063 - Efficacy and Safety of Tocovid Suprabio 200mg in Non-alcoholic Fatty Liver (NAFL) | Biotech Hunter | Biotech Hunter